We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Anti-Ebola MVA Vaccine Produced on Avian AGE1.CR® Cell Line in Clinical Trials

News   Jun 03, 2015

 
Anti-Ebola MVA Vaccine Produced on Avian AGE1.CR® Cell Line in Clinical Trials
 
 
Advertisement
 

RELATED ARTICLES

Denmark To Suspend Rollout of AstraZeneca COVID-19 Vaccine

News

The Danish Health Authority has decided to continue its vaccination programme against COVID-19 without the vaccine from AstraZeneca.

READ MORE

The FDA Calls for Pausing the Use of the Johnson & Johnson COVID-19 Vaccine

News

The United States Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) have recommended pausing the use of the Johnson & Johnson (Janssen) COVID-19 vaccine. In addition, Janssen has declared that it will "proactively delay" the rollout of the vaccine in Europe.

READ MORE

Asthma Drug Reduces Recovery Time in Non-Hospitalized Patients With COVID-19

News

Inhaled budesonide, has been found to shorten recovery times in COVID-19 patients aged over 50 years who are treated at home and in other community settings, according to the UK’s PRINCIPLE trial of 1,779 participants.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE